scholarly journals Antagonistic Effects of Interferon-γ and Interleukin-4 on Fibroblast Cultures.

1997 ◽  
Vol 109 (2) ◽  
pp. 158-162 ◽  
Author(s):  
Hervé Serpier ◽  
Philippe Gillery ◽  
Véronique Salmon-Ehr ◽  
Roselyne Garnotel ◽  
Nadine Georges ◽  
...  
1990 ◽  
Vol 20 (2) ◽  
pp. 243-251 ◽  
Author(s):  
Isabelle Chrétien ◽  
Jér??me Pène ◽  
Francine Brière ◽  
René De Waal Malefijt ◽  
Françoise Rousset ◽  
...  

2014 ◽  
Vol 42 (5) ◽  
pp. 465-471 ◽  
Author(s):  
M. Nabavi ◽  
S. Arshi ◽  
A. Bahrami ◽  
Z. Aryan ◽  
M.H. Bemanian ◽  
...  

1994 ◽  
Vol 24 (6) ◽  
pp. 1441-1445 ◽  
Author(s):  
Anthony G. Doyle ◽  
Georges Herbein ◽  
Luis J. Montaner ◽  
Adrian J. Minty ◽  
Daniel Caput ◽  
...  

1992 ◽  
Vol 13 (9) ◽  
pp. 323-328
Author(s):  
Frank S. Virant

Epidemiology Allergic rhinitis affects as many as 8% to 10% of children in the United States. Many of these children suffer significant morbidity, leading to millions of lost school days annually. Morbidity is amplified when these children concurrently suffer from complications of allergic rhinitis, such as recurrent otitis media or chronic sinus disease. Typically, children who have allergic rhinitis have a family history of atopic disorders. Upper airway allergy may become manifest at any age, but the appearance of symptoms is most common during childhood or young adulthood. Clinical signs of rhinitis may be perennial, seasonal, or episodic, and the primary focus of complaints may relate to secondary problems, including ear, sinus, or lung disease. Pathophysiology In the allergic patient, disease is mediated by the production of antigenspecific IgE by the patient's B lymphocytes. Current research suggests that the primary defect may be the excessive production of interleukin 4 (IL-4) or a deficient level of gamma interferon (γ-INF) when a T-cell is presented with an antigen. This constellation of immunomodulators directs the B-cell to produce IgE rather than the IgG response of the non-allergic patient. Clinical disease occurs when an allergen reacts with antigen-specific IgE on the patient's nasal mast cells. When these factors combine, the mast cell is activated to release a variety of preformed and newly produced mediators, including histamine, leukotrienes, and prostaglandins (Fig 1).


2008 ◽  
Vol 66 (3b) ◽  
pp. 678-684 ◽  
Author(s):  
Soniza Vieira Alves-Leon ◽  
Maria Lucia Vellutini Pimentel ◽  
Gabrielle Sant'Anna ◽  
Fabíola Rachid Malfetano ◽  
Cláudio Duque Estrada ◽  
...  

Neuromyelitis optica (NMO) is an inflammatory, demyelinating disease of the central nervous system characterized by the association of a serious myelitis and unilateral or bilateral optic neuritis. The present study aimed to analyze the immunological parameters of NMO patients with diagnosis established based on Wingerchuck et al. (1999) criteria. Production of IgG and IgA antibodies to antigens of MBP, PLP 95-116, MOG 92-106, and the cytokines interleukin-4 (IL-4) and interferon-γ (INF-γ) were assessed by Elisa assay. The cohort was formed by 28 NMO patients and a matched healthy control group. NMO patients had significant high levels of IgG to MOG (p<0.0001), PLP (p=0.0002) and MBP (p<0.0001), and solely IgA to MBP (p<0.0001). INF-γ (p=0.61) levels were similar to healthy controls. Increased production of IL-4 (p=0.0084) indicates an important role for this cytokine in the activation of Th2 regulatory cells and of the IgA producers B lymphocyte indicating activation of humoral immunity.


Sign in / Sign up

Export Citation Format

Share Document